跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,542 条关于
“Refractory hypercholesterolemia”
全部
15,542
临床试验
12,951
药物
87
机构
12
资讯
2,492
18天前
ANGPTL3 Inhibitors Market Poised to Reach $3.48 Billion by 2035 as Pipeline Diversifies Beyond Monoclonal Antibodies
去年
Editas Medicine Achieves 90% LDL Cholesterol Reduction with EDIT-401 Gene Therapy in Preclinical Studies
去年
Eli Lilly Acquires Verve Therapeutics for $1.3 Billion to Advance One-Time Gene Editing Treatments for Cardiovascular Disease
去年
Eli Lilly Acquires Gene-Editing Biotech Verve Therapeutics for $1.3 Billion to Expand Cholesterol Treatment Pipeline
去年
Verve Therapeutics Advances Pipeline with Focus on Gene Editing for Cardiovascular Disease
去年
Homozygous Familial Hypercholesterolemia Treatment Market to Surge by 2034
去年
Comprehensive Treatment Options Expand for Non-Familial Hypercholesterolemia Management
3个月前
Cost-Effectiveness of Genome-Guided Statin Treatment for Hypercholesterolemia
2个月前
Everest Medicines' LEROCHOL BLA Accepted by China NMPA for Hypercholesterolemia
6个月前
FDA Approves Juxtapid for Pediatric Patients with Homozygous Familial Hypercholesterolemia
第 1 页，共 250 页
上一页
下一页
